NCT02170987View on ClinicalTrials.gov

Assessment of Electrophysiological Effects of Dabigatran Etexilate as Single Dose on the QT Interval in Healthy Female and Male Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

May 31, 2006

Conditions
Healthy
Interventions
DRUG

Dabigatran etexilate low

DRUG

Dabigatran etexilate high

DRUG

Moxifloxacin

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY